drugset / Trial / NCT00189930
An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of the study is to compare two doses of MVA-nef vs. MVA-BN to induce Nef-specific cellular immune response in HIV-1 infected patients
Timeline
- Start
- 2005-04
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MVA-nef | Vaccine | 1e+08 unknown | — |
| Comparator | MVA-nef | Vaccine | 5e+08 unknown | — |